| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8528595 | Current Opinion in Pharmacology | 2018 | 5 Pages |
Abstract
Evaluating combinations of different inhibitors, dosing and sequencing within a multimodal therapy approach, together with better management of toxicity represents a new challenge for future research of therapy targeting immune check-points.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Andrea Bianco, Umberto Malapelle, Danilo Rocco, Fabio Perrotta, Gennaro Mazzarella,